Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000387338

Medchemexpress LLC Bleomycin (sulfate) | 9041-93-4 | 99.49% | 1523 (average) | 100 MG
SDP

Catalog No. 5000387338
Encompass_Preferred

Bleomycin sulfate is a DNA synthesis inhibitor and an antitumor antibiotic. It acts as a DNA damaging agent, causing single and double strand breaks and single apurinic/apyrimidinic sites in DNA. This radiomimetic compound is used to induce pulmonary fibrosis models and is rapidly absorbed with high bioavailability.

  • DNA synthesis inhibitor
  • Antitumor antibiotic
  • Radiomimetic compound, resembling the genetic effect of ionizing radiation
  • Causes single and double strand breaks and single apurinic/apyrimidinic sites in DNA
  • Can be used to induce pulmonary fibrosis models
  • Rapidly absorbed after intramuscular, subcutaneous, intraperitoneal, or intrapleural administration
  • Reaches peak plasma concentrations in approximately 60 minutes
  • Less than 1% binds to plasma proteins
  • High bioavailability
  • Mean plasma clearance rate of about 70 mL/min/m2

Catalog No. 50-003-87338 Supplier Medchemexpress LLC Supplier No. HY17565100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bleomycin sulfate is a DNA synthesis inhibitor and an antitumor antibiotic. It acts as a DNA damaging agent, causing single and double strand breaks and single apurinic/apyrimidinic sites in DNA. This radiomimetic compound is used to induce pulmonary fibrosis models and is rapidly absorbed with high bioavailability.

  • DNA synthesis inhibitor
  • Antitumor antibiotic
  • Radiomimetic compound, resembling the genetic effect of ionizing radiation
  • Causes single and double strand breaks and single apurinic/apyrimidinic sites in DNA
  • Can be used to induce pulmonary fibrosis models
  • Rapidly absorbed after intramuscular, subcutaneous, intraperitoneal, or intrapleural administration
  • Reaches peak plasma concentrations in approximately 60 minutes
  • Less than 1% binds to plasma proteins
  • High bioavailability
  • Mean plasma clearance rate of about 70 mL/min/m2

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.